Los Angeles, California
Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
Bachelor of Science (BS)
Bachelor of Science (BS)
2018
2020
Cavallo Ventures is the venture capital arm of Wilbur-Ellis, a privately owned family business approaching its centennial anniversary. We invest our own capital and are looking for pioneering entrepreneurs that insist upon building successful companies without taking shortcuts. Current Portfolio: AgCode, ACG, AgroSpheres, Ascus Biosciences, Beta Hatch, Boost Biomes, Bountiful Ag, Crop Enhancement, Farmwise, FieldIn, Geltor, Sabanto, SomaDetect, Sound Ag, Smartwyre, Trace Genomics, Verdant Robotics, Vow Foods, Kuehnle Agrosystems, Andes Ag, Debut Bio, MicroTerra Exits: Performance Livestock Analytics (Acquired by Zoetis)
2018 - 2020
2018
2018
AgCode empowers farming operations with the leading software solution in specialty crops. The company provides the agriculture industry with mission-critical services, delivering unified data and business intelligence to maximize efficiency and productivity.
2020 - 2023
2020 - 2023
2016 - 2017
2016 - 2017
2nd/3rd year analyst focused on strategic advisory, M&A, and capital raising for life sciences and medical device companies. Completed over 20 transactions representing $2B+ in total deal value. Selected transactions include: •HemoShear Therapeutics' drug discovery partnership with Takeda Pharmaceutical (Up to $470M) •NuCana $115M IPO •Sangamo Therapeutics $83M Follow-On •Albireo Pharma $52M Follow-On •GlycoMimetics $93M Follow-On •G1 Therapeutics $117M IPO •Nexvet's $85M sale to Zoetis •Editas Medicine $104M Follow-On •Heron Therapeutics $173M Follow-On •Bird Rock Bio's acquisition option agreement with Janssen Pharmaceuticals ($100M+) •NantHealth $107M Convertible Senior Notes •Alliqua BioMedical's $37M acquisition of Soluble Systems (Withdrawn) •Foamix Pharmaceuticals $61M Follow-On •OncoCyte $11M PIPE •Alimera Sciences $26M Follow-On •Avinger $35M Follow-On •ACADIA Pharmaceuticals $230M Follow-On •Audentes Therapeutics $85M IPO •GW Pharmaceuticals $290M Follow-On •GlycoMimetics $21M Follow-On
2015 - 2016
2015 - 2016
Sell-side M&A and capital raising for technology and business services companies. Selected transactions include: •Sale of Spring Studio to BBVA •Sale of InterVision to RLG Capital
2013 - 2014
2013 - 2014